Breckenridge announces launch of Milnacipran HCl Tablets, generic equivalent of Savella(R)

Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, today announced the launch of Milnacipran HCl ...
Monthly Prescribing Reference

Meloxicam Tablets Mislabeled as Cyclobenzaprine HCl Prompt Recall

The recall involves Lot# GMML24026A (NDC# 29300-415-19) with an expiration date of September 2027. Unichem Pharmaceuticals is recalling 1 lot of Cyclobenzaprine Hydrochloride Tablets USP, 10mg due to ...

Glenmark Pharmaceuticals Inc. launches Milnacipran Hydrochloride Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg, and 100 mg.
Trade Brains on MSN

Can Glenmark Pharma capture the $384 mil US nasal spray market from Haleon?

India, March 19 -- Glenmark Pharmaceuticals has made its presence in the US stronger by launching two important products in the pain and allergy markets. The company has launched Milnacipran ...

Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...
Seeking Alpha

Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia

CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) ...